Tag
GLP-1
Page 4 of 5
Survodutide cleared liver fat in 84% of patients
A Nature Medicine phase 3 trial of 216 adults found survodutide cut liver fat by at least 30% in 84.2% of those treated, against 24.3% on placebo, alongside 12.2% weight loss.
Jul 27, 2026
Exercise improved arteries where liraglutide did not
A Nature Metabolism analysis of 130 adults keeping weight off found exercise thinned artery walls and cut inflammation, while the drug liraglutide alone did neither despite similar weight control.
Jul 26, 2026
Oral GLP-1 pill elecoglipron hit 10% weight loss in a trial
A Lancet phase 2 trial of 310 adults found the oral GLP-1 drug elecoglipron produced up to 10.5% weight loss in 26 weeks against 0.6% on placebo, with no injections and no food restrictions.
Jul 26, 2026
Apitegromab kept muscle on during tirzepatide weight loss
A Nature Medicine trial of 102 adults found adding the antibody apitegromab to tirzepatide cut lean-mass loss by 1.9 kilograms over 24 weeks, without slowing total weight loss.
Jul 25, 2026